Braxia Scientific Corp.
CNQ: BRAX.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peter Rizakos
- Headquarters
- Toronto, Canada
- IPO year
- 2020
- Market cap
- CA$1.4M
- Website
- https://braxiascientific.com
Loading BRAX…
Loading profile data…Frequently asked questions about BRAX
What does Braxia Scientific Corp. (BRAX.CN) do?
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discoverin...
Where does BRAX.CN trade?
Braxia Scientific Corp. (BRAX.CN) trades on the Canadian Securities Exchange.
What sector is BRAX.CN in?
Braxia Scientific Corp. (BRAX.CN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Braxia Scientific Corp.?
Peter Rizakos is the chief executive officer of Braxia Scientific Corp. (BRAX.CN).
Where is Braxia Scientific Corp. headquartered?
Braxia Scientific Corp. is headquartered in Canada.
Does BRAX.CN pay a dividend?
Braxia Scientific Corp. (BRAX.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BRAX.CN go public?
Braxia Scientific Corp. (BRAX.CN) completed its initial public offering in 2020.